This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare (THC) Unit Ties Up to Boost Urology Services
by Zacks Equity Research
Tenet Healthcare's (THC) unit, USPI, signs a joint venture partnership with UUG to acquire ownership interests in the latter's 22 ambulatory surgery centers and concurrently assuring to develop these centers.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Tenet Healthcare (THC) Unit Conifer Offers Services to Brookwood
by Zacks Equity Research
Tenet Healthcare's (THC) unit Conifer inks an agreement with Brookwood Baptist Health to deliver enhanced revenue cycle services to four of the remaining hospitals of the latter across Central Alabama.
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Should iShares Russell 2000 Value ETF (IWN) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWN
Why Is Tenet (THC) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
by Zacks Equity Research
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Centene (CNC) Q1 Earnings Beat Estimates, Ups '22 EPS View
by Zacks Equity Research
Centene's (CNC) first-quarter results highlight improved premium and service revenues and, higher membership growth. An increased 2022 guidance with respect to EPS and revenues should impress investors.
Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Tenet Healthcare (THC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 85.58% and 1.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Tenet Healthcare (THC) Post Q1 Earnings Beat on Low Costs?
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter 2022 results are likely to reflect an improvement in adjusted admissions and outpatient admissions.
Is a Surprise Coming for Tenet Healthcare (THC) This Earnings Season?
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
UnitedHealth's (UNH) Q1 Earnings Surpass Mark, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q1 results reflect gains from both its segments, Optum and UnitedHealthcare, along with higher revenues.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Relocates North Alabama Hospital
by Zacks Equity Research
Encompass Health (EHC) commences operations in its North Alabama hospital, which has been relocated with added capacity for better serving residents of the Huntsville community.
Ensign Group (ENSG) on Buyout Spree, Adds New Properties
by Zacks Equity Research
Ensign Group (ENSG) acquires the operations of certain living facilities in California and Washington to bolster its portfolio.
Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?
by Zacks Equity Research
Growing revenues, strong performances exhibited by segments, numerous acquisitions and sturdy financial standing continue to drive Tenet Healthcare (THC).
Should Value Investors Pick Tenet Healthcare (THC) Stock Now?
by Zacks Equity Research
Let's see if Tenet Healthcare Corporation (THC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Tenet (THC) Up 16.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Inaugurates New Hospital in Florida
by Zacks Equity Research
Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.
Acadia Healthcare (ACHC) Eyes Over 600 Bed Additions in 2022
by Zacks Equity Research
Acadia Healthcare (ACHC) has two de novo projects in Chicago and Indio, CA, which are expected to add a total of around 140 beds this year.